Several recent studies have further evaluated AC-4-130 in lymphoma and AML, characterizing the role of STAT5 in maintenance of stemness, PDGFRβ-mediated oncogenic signaling, and FLT3 or TET2 mutated leukemias [230,231,232]. The gene discussed is STAT5A; the disease is acute myeloid leukemia.